MedTrace Logo

Effect of OMEGA3 Supplementation in Diabetic Retinopathy

NCT04499820 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-12-04

No results posted yet for this study

Summary

The main objective of this study is to evaluate the efficacy at 6 months of omega 3 supplementation on macular capillary density measured in optical coherence tomography angiography in patients with minimal or moderate non proliferative diabetic retinopathy.

Conditions

Interventions

DIETARY_SUPPLEMENT

Nutrof

DHA docosahexaenoic acid Omega 3s may be of interest in cases of retinopathies.

DIETARY_SUPPLEMENT

Meralut

vitamin A, natural flavonoids, lutein and zeaxanthin

Sponsors & Collaborators

  • Laboratoires Thea

    collaborator INDUSTRY

  • Centre Hospitalier Intercommunal Creteil

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-26
Primary Completion
2024-10-10
Completion
2025-04-17

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04499820 on ClinicalTrials.gov